2025年欧洲肿瘤内科学会亚洲年会(ESMO ASIA CONGRESS 2025)

◆ 会议时间：2025年12月5-7日
◆ 会议地点：新加坡/Singapore – Suntec Singapore Convention & Exhibition Centre

◆ 会议简介：

2025年欧洲肿瘤内科学会(ESMO)亚洲年会（大会）将于2025年12月5-7日在新加坡举行，会议由欧洲肿瘤内科学会(ESMO)主办。ESMO亚洲年会（ESMO ASIA CONGRESS 2024）将汇聚最具经验的国际专家，提供高水准的涵盖所有主要肿瘤类型的肿瘤学教育方案，并为国际同行提供重要的交流机会，使亚太地区的肿瘤学专业人士能够与快速发展的肿瘤学科学与教育保持同步。ESMO亚洲大会是全球和亚洲临床医生战略合作的结果，将由来自世界各地的顶级肿瘤学专家提供的一流的科学和教育项目，大会是亚太地区讨论肿瘤学领域的最新数据和最新突破成果的领先平台，并重点关注区域特性。

欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织，ESMO一直以宣推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

2025 ESMO Asia Congress – European Society for Medical Oncology Asia Congress

Date: 5-7 December 2025
Venue: Suntec Singapore Convention & Exhibition Centre, Singapore, Republic of Singapore

Welcome to the ESMO Asia Congress 2025!

ESMO Asia is a key gathering for oncology professionals across the Asia-Pacific region, bringing together top experts, researchers, and healthcare providers to advance cancer care and research.

Join us for an exceptional opportunity to explore cutting-edge science, groundbreaking therapies, and innovative practices shaping the future of oncology.

Taking place in Singapore, this annual event features a diverse and dynamic programme, including plenary sessions, multidisciplinary tumour boards, “Meet the Expert” sessions, poster presentations, and networking opportunities. Gain insights into the latest clinical advancements and engage in meaningful discussions with leading minds in oncology.

The ESMO Asia Congress 2025 welcomes participants from all disciplines and levels of expertise, fostering collaboration and the exchange of knowledge.

Save the date and prepare to be part of a transformative journey in cancer research and treatment.

下为上届信息

摘要征文投稿：

Abstract submission deadlines

Abstracts

Trial in Progress

Intent to submit LBA

Tuesday, 16 July 2024

18:00 SGT (Local Singapore Time)

12:00 CEST (Central European Summer Time)

Late-breaking abstracts (LBA)

Tuesday, 8 October 2024

18:00 SGT (Local Singapore Time)

12:00 CEST (Central European Summer Time)

A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline of 16 July 2024

点此提交摘要>>>Submit Abstract>>>

ESMO Asia Congress 2024 Abstract Regulations

Outcome notifications

Outcome notifications are expected to be made available to first authors and submitters by mid-September 2024.

Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by mid-October 2024.

Information for presenters

Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid-September 2024, in the section “Information for Presenters”.

Abstract submission categories

Breast cancer, early stage	Head and neck cancer, excluding thyroid
Breast cancer, locally advanced	Palliative care
Breast cancer, metastatic	Precision medicine
Developmental therapeutics	Supportive care
Gastrointestinal tumours, colorectal	Thoracic tumours, early stage
Gastrointestinal tumours, non-colorectal	Thoracic tumours, locally advanced
Genitourinary tumours, prostate	Thoracic tumours, metastatic
Genitourinary tumours, non-prostate	Miscellaneous
Gynaecological cancers

Late-breaking abstracts (LBA)

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.

The final late-breaking abstract deadline of 8 October 2024 is under no circumstances to be considered as an extension of the general submission deadline (16 July 2024).

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Asia Congress 2024.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Young Oncologist (YO) Patient case studies

Challenging clinical case studies in the new era of personalised medicine may be submitted by young oncologists under 40 years of age.

Presentation and publication of accepted abstracts

The ESMO Asia 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

Presidential Symposium – Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts, including late-breaking abstracts, will be published online only in the ESMO Asia Congress 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

Publication schedule of accepted abstracts

Details regarding the publication of accepted abstracts will be available here.

ESMO Merit Travel Grants

A limited number of Merit Travel Grants to the ESMO Asia Congress 2024 are available, upon application, to first authors who submit abstracts considered deserving of recognition. Candidates must be ESMO members under the age of 40 (forty). Selection will be made by the ESMO Asia Congress 2024 Scientific Committee on a competitive basis from among the accepted abstracts.

注册费：

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in SGD by the given deadlines.

ESMO membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied Please visit the membership page to check eligibility criteria, benefits, and to complete the membership application.

Registration fees for onsite only (Net amounts, SGD)	Early registration fee until 4 September 2024	Late registration fee until 6 November 2024	Full registration fee from 7 November 2024
ESMO Member	SGD 425.00	SGD 620.00	SGD 930.00
ESMO Member Developing Countries*	SGD 172.00	SGD 258.00	SGD 287.00
ESMO Member in Training**	SGD 121.00	SGD 155.00	SGD 207.00
ESMO Member Undergraduate Student	SGD 121.00	SGD 155.00	SGD 207.00
ESMO Member Nurse	SGD 121.00	SGD 155.00	SGD 207.00
ESMO Member Patient Advocate	SGD 121.00	SGD 155.00	SGD 207.00
Non-Member	SGD 654.00	SGD 955.00	SGD 1,448.00

* Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO Members must be under 40 and in training to qualify for this fee

In-person participation includes:

Participation in the scientific and educational live sessions with the possibility to interact with the expert panel table
Onsite networking opportunity with faculty and peers
Entry to the Poster area
Interaction with the industry partners in the trade exhibition
Participation in the Industry Satellite Symposia
Post-event resources

Other registration fees for onsite only (Net amounts, SGD)	Fee	Access
Exhibitor visitor badge	SGD 182.00	Exhibition area Industry satellite area Private meeting area Access to sessions and webcast not included
Private meeting badge
Industry satellite badge
Third Party Media	SGD 400.00	Venue common areas Filming area Exhibition area and Private meeting rooms upon invitation only Access to sessions and webcast not included